CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
+11.62%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$104B
AUM Growth
+$832M
(+0.8%)
Cap. Flow
-$8.36B
Cap. Flow
% of AUM
-8.01%
Top 10 Holdings %
Top 10 Hldgs %
24.95%
Holding
3,100
New
50
Increased
1,214
Reduced
1,289
Closed
124
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$198M |
| 2 |
UBS Group
UBS
|
$115M |
| 3 |
Flutter Entertainment
FLUT
|
$62.4M |
| 4 |
Eli Lilly
LLY
|
$53.1M |
| 5 |
Dynatrace
DT
|
$46.7M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$525M |
| 2 |
Apple
AAPL
|
$332M |
| 3 |
Invesco QQQ Trust
QQQ
|
$296M |
| 4 |
Microsoft
MSFT
|
$259M |
| 5 |
Amazon
AMZN
|
$206M |
Sector Composition
| 1 | Technology | 27.94% |
| 2 | Financials | 15.29% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 9.6% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Workhorse Group
WKHS
$19.4M
| $153K | ﹤0.01% |
2,611
+25
| +1% | +$1.47K |
|
|
HIMX
2827
Himax Technologies
HIMX
$1.46B
| $146K | ﹤0.01% |
27,376
+688
| +3% | +$3.68K |
|
2828
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $140K | ﹤0.01% |
58,431
-262,070
| -82% | -$626K |
|
2829
1stdibs.com
DIBS
$100M
| $139K | ﹤0.01% |
23,361
| – | – |
|
2830
TScan Therapeutics
TCRX
$108M
| $138K | ﹤0.01% |
+17,366
| New | +$138K |
|
2831
BRF SA
BRFS
$5.86B
| $133K | ﹤0.01% |
40,824
-29,215
| -42% | -$95.2K |
|
2832
Black Diamond Therapeutics
BDTX
$167M
| $130K | ﹤0.01% |
25,600
| – | – |
|
2833
Absci
ABSI
$368M
| $125K | ﹤0.01% |
21,920
| – | – |
|
|
ME
2834
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $121K | ﹤0.01% |
11,365
| – | – |
|
|
QVCGA
2835
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $119K | ﹤0.01% |
1,928
-34
| -2% | -$2.09K |
|
2836
Skillsoft
SKIL
$132M
| $113K | ﹤0.01% |
12,556
| – | – |
|
2837
CS Disco
LAW
$344M
| $111K | ﹤0.01% |
13,688
+2,569
| +23% | +$20.9K |
|
2838
Monte Rosa Therapeutics
GLUE
$305M
| $110K | ﹤0.01% |
15,600
-4,400
| -22% | -$31K |
|
2839
Crawford & Co Class A
CRD.A
$540M
| $107K | ﹤0.01% |
+11,333
| New | +$107K |
|
2840
Amylyx Pharmaceuticals
AMLX
$910M
| $104K | ﹤0.01% |
36,643
-1,409
| -4% | -$4K |
|
|
CMRX
2841
DELISTED
Chimerix, Inc.
CMRX
| $99.6K | ﹤0.01% |
94,000
-40,000
| -30% | -$42.4K |
|
2842
Entravision Communication
EVC
$226M
| $90K | ﹤0.01% |
54,854
+3,740
| +7% | +$6.13K |
|
2843
Scilex Holding
SCLX
$159M
| $89.5K | ﹤0.01% |
1,608
-1
| -0.1% | -$56 |
|
|
JMIA
2844
Jumia Technologies
JMIA
$1.09B
| $88.8K | ﹤0.01% |
17,353
-41,505
| -71% | -$213K |
|
2845
AN2 Therapeutics
ANTX
$34.4M
| $86.5K | ﹤0.01% |
+26,630
| New | +$86.5K |
|
2846
Telecom Argentina
TEO
$3.67B
| $79.5K | ﹤0.01% |
+10,000
| New | +$79.5K |
|
2847
DDC Enterprise Ltd
DDC
$90.9M
| $63.7K | ﹤0.01% |
+2,088
| New | +$63.7K |
|
|
MOMO
2848
Hello Group
MOMO
$1.37B
| $63.4K | ﹤0.01% |
10,212
-114,586
| -92% | -$712K |
|
2849
Caribou Biosciences
CRBU
$174M
| $57.6K | ﹤0.01% |
11,210
| – | – |
|
|
TIGR
2850
UP Fintech Holding
TIGR
$2.18B
| $57.4K | ﹤0.01% |
16,700
-3
| -0% | -$10 |
|